☆ 4.6 Article

Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants

JOURNAL OF VIROLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

Wilfredo F. Garcia-Beltran et al.

Summary: Recent surveillance has identified the emergence of the SARS-CoV-2 Omicron variant, which carries up to 36 mutations in the spike protein and has the potential to evade vaccine-induced immunity. This study found that individuals vaccinated with mRNA vaccines exhibited strong neutralization of the Omicron variant, while most vaccinees had weak neutralization. The study also revealed that the Omicron variant infects more efficiently than other tested variants.

CELL (2022)

添加到收藏夹

Article Microbiology

SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape

Sandile Cele et al.

Summary: Characterizing the evolution of SARS-CoV-2 in an individual with advanced HIV disease in South Africa, this study found that the evolved virus showed immune escape of vaccines and enhanced escape of Delta immunity. This suggests that immune-compromised hosts may play a significant role in the evolution of the virus.

CELL HOST & MICROBE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Raquel Viana et al.

NATURE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

S. Momsen Reincke et al.

Summary: The Beta variant of concern (VOC) of SARS-CoV-2 shows resistance to neutralization by antibodies from COVID-19 patients and vaccinated individuals. Researchers have identified specific antibodies in serum from Beta-infected patients that are able to cross-react with the wild type virus. This finding provides insights into the antibody response to antigenic drift and has implications for the development of future vaccines and therapeutics.

SCIENCE (2022)

添加到收藏夹

Article Microbiology

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy

Allison Greaney et al.

Summary: SARS-CoV-2 variants can elicit polyclonal antibodies with different immunodominance hierarchies. The antibodies elicited by infection with B.1.351 variant are more focused on the class 3 epitope, which is mutated in the Delta variant. Prior infection and vaccination histories may partially determine individuals' susceptibilities to viral mutants in new variants.

PLOS PATHOGENS (2022)

添加到收藏夹

Review Immunology

SARS-COV-2 Variants: Differences and Potential of Immune Evasion

Sandro M. Hirabara et al.

Summary: This review addresses key issues regarding SARS-CoV-2 variants, including the characteristics of variants with mutations in the S gene, evasion of neutralizing antibodies, potential risks of new pandemic waves, and prospects for further research and actions to prevent or reduce the impact of new variants during the current COVID-19 pandemic.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

添加到收藏夹

Article Microbiology

SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals

Simone I. Richardson et al.

Summary: The Omicron variant of SARS-CoV-2 can evade neutralizing antibodies generated by either vaccines or previous infection. However, it is unclear whether Omicron can trigger cross-reactive immune responses to other variants of concern (VOCs). A study found that unvaccinated individuals produced binding antibodies and functional antibodies at similar levels against Omicron and other VOCs, but the neutralizing activity against VOCs was significantly reduced compared to Omicron. On the other hand, vaccinated individuals who experienced breakthrough Omicron infection had enhanced cross-neutralization against VOCs, indicating a potential benefit of vaccination in protecting against circulating and emerging variants.

CELL HOST & MICROBE (2022)

添加到收藏夹

Letter Immunology

Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance

Prerna Arora et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Letter Infectious Diseases

The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients

Elisa Teyssou et al.

JOURNAL OF INFECTION (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sandile Cele et al.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Detection of a SARS-CoV-2 variant of concern in South Africa

Houriiyah Tegally et al.

Summary: The article describes a newly emerged lineage of SARS-CoV-2, 501Y.V2, characterized by eight mutations in the spike protein, which may result in increased transmissibility or immune escape. This lineage originated in South Africa and quickly became dominant in Eastern Cape, Western Cape, and KwaZuluNatal provinces within weeks.

NATURE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Constantinos Kurt Wibmer et al.

Summary: The SARS-CoV-2 virus in the B.1.351 variant discovered in South Africa can evade neutralization by most antibodies when expressed, but does not affect binding by convalescent plasma. This suggests the potential for reinfection with antigenically distinct variants and predicts reduced efficacy of spike-based vaccines.

NATURE MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies

Erik Laurini et al.

Summary: The study found that certain mutations in the SARS-CoV-2 spike protein can significantly resist antibody neutralization, while others can help the viral protein evade antibody action. Overall, there was a 90% agreement between the global in silico results and relevant experimental data, providing a molecular rationale and a tool for identifying circulating variants and developing more resilient vaccines and monoclonal antibodies.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Microbiology

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

Liane Dupont et al.

Summary: The design and rollout of COVID-19 vaccines should consider the durability and cross-neutralizing potential of antibodies against SARS-CoV-2 and emerging variants. Studies on convalescent sera show that cross-neutralizing activity can last up to 305 days post onset of symptoms, with differences in neutralization potency against variants decreasing over time due to antibody maturation.

NATURE MICROBIOLOGY (2021)

添加到收藏夹

Article Microbiology

A human coronavirus evolves antigenically to escape antibody immunity

Rachel T. Eguia et al.

Summary: This study investigates the evolution of human coronavirus 229E and finds that as the virus evolves, mutations in the spike protein can escape neutralization by antibodies in old human sera. The results suggest that viral evolution may impact immunity, highlighting the need for periodic updates to coronavirus vaccines.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Chang Liu et al.

Summary: Recent study examined the neutralizing ability of monoclonal antibodies, convalescent and vaccine sera against the Indian variants B.1.617.1 and B.1.617.2, showing that the neutralization of these variants is reduced compared to the ancestral strains, without widespread antibody escape as seen in other variants like B.1.351.

CELL (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages

Darren P. Martin et al.

Summary: The emergence of the 501Y lineages of SARS-CoV-2 in 2020 coincided with a global shift in selective forces acting on various genes, leading to repeated convergent mutations at 35 genome sites known as the 501Y meta-signature. This meta-signature includes multiple mutation combinations that promote the persistence of diverse SARS-CoV-2 lineages in the face of increasing host immune recognition.

CELL (2021)

添加到收藏夹

Letter Cell Biology

Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants

Hua Xu et al.

CELL RESEARCH (2021)

添加到收藏夹

Article Immunology

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations

Frauke Muecksch et al.

Summary: This study examined the development of antibodies following infection with the coronavirus, finding that evolved antibodies had increased affinity and neutralization potency, altered mutational pathways for viral resistance, and restricted neutralization escape options. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying populations of the virus and other pandemic threat coronaviruses.

IMMUNITY (2021)

添加到收藏夹

Article Cell Biology

Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection

Allison J. Greaney et al.

Summary: Vaccine-elicited antibodies have more focused neutralizing activity on the RBD of the SARS-CoV-2 spike protein, while infection-elicited antibodies have broader binding across epitopes; hence, single RBD mutations have less impact on neutralization by vaccine sera.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Bin Ju et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells

Yunlong Cao et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Luca Piccoli et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis of a shared antibody response to SARS-CoV-2

Meng Yuan et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Christopher O. Barnes et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality

Tomer Zohar et al.

CELL (2020)

添加到收藏夹

Article Virology

New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

Nicole A. Doria-Rose et al.

JOURNAL OF VIROLOGY (2016)

添加到收藏夹

Article Immunology

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

Cynthia A. Derdeyn et al.

CURRENT OPINION IN HIV AND AIDS (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

Florian Klein et al.

CELL (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

Johannes F. Scheid et al.

SCIENCE (2011)

添加到收藏夹

Article Biochemical Research Methods

High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies

Hua-Xin Liao et al.

JOURNAL OF VIROLOGICAL METHODS (2009)

添加到收藏夹

Article Biochemical Research Methods

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

Thomas Tiller et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.